Multi-lab research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets. A major scientific effort is underway to characterize the proteins in the cerebrospinal fluid to improve diagnostics and clinical monitoring assays and discover potential therapies, for Alzheimer’s disease. Several research labs at the University of Washington School of Medicine and Stanford...
